Zevra Therapeutics, Inc. (ZVRA)

NASDAQ: ZVRA · IEX Real-Time Price · USD

4.520

+0.020 (0.44%)

At close: Apr 19, 2024, 4:00 PM

4.425

-0.095 (-2.10%)

After-hours: Apr 19, 2024, 5:27 PM EDT

Zevra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Equivalents	43.05	65.47	112.35	4.32	3.56	19.12	11.97	17.86	32.32	10.26	Upgrade
Short-Term Investments	24.69	17.38	0	0	0	3.26	31.36	51	19	0	Upgrade
Cash & Cash Equivalents	67.74	82.85	112.35	4.32	3.56	22.38	43.33	68.87	51.32	10.26	Upgrade
Cash Growth	-18.24%	-26.26%	2499.40%	21.58%	-84.11%	-48.35%	-37.08%	34.19%	400.44%	420.92%	Upgrade
Receivables	17.38	8.3	1.53	2.58	1.87	0.14	2.01	5	0	0	Upgrade
Inventory	9.84	0.67	0	0	0	0	0	0	0	0	Upgrade
Other Current Assets	-8.02	1.02	1.18	1.48	1.55	1.2	0.56	0.49	2.76	0.02	Upgrade
Total Current Assets	86.94	92.83	115.06	8.38	6.97	23.72	45.9	74.36	54.08	10.28	Upgrade
Property, Plant & Equipment	1.53	1.78	2.03	2.39	3.01	1.75	2	1.97	0.4	0.35	Upgrade
Long-Term Investments	0	20	15.42	0	0	0	3.25	8.2	0	0	Upgrade
Goodwill and Intangibles	73.93	0	0	0	0	0	0	0	0	0	Upgrade
Other Long-Term Assets	9.94	0.72	0.44	0.44	0.53	1.27	1.31	0.36	0.11	3.08	Upgrade
Total Long-Term Assets	85.39	22.51	17.89	2.83	3.54	3.03	6.56	10.53	0.51	3.44	Upgrade
Total Assets	172.33	115.34	132.94	11.21	10.51	26.75	52.46	84.89	54.59	13.71	Upgrade
Accounts Payable	28.4	6.17	3.04	6.65	4.91	8.34	7.88	6.44	4.91	3.1	Upgrade
Deferred Revenue	12.21	8.98	0	0	0	0	0	0	0	0	Upgrade
Current Debt	38.24	0.48	0.36	0.72	0.28	3.55	3.52	0.16	3.44	0.84	Upgrade
Other Current Liabilities	-5.14	-3.61	0.84	0.17	0.24	0.12	0.11	0.04	0	0	Upgrade
Total Current Liabilities	73.72	12.02	4.23	7.54	5.43	12	11.51	6.64	8.34	3.94	Upgrade
Long-Term Debt	5.52	13.64	1.23	69.64	79.24	78.5	89.96	91.83	18.53	18.11	Upgrade
Other Long-Term Liabilities	31.22	14.55	0.36	0.45	0.29	2.81	8.5	5.11	37.84	15.97	Upgrade
Total Long-Term Liabilities	36.74	28.2	1.59	70.09	79.53	81.31	98.46	96.94	56.37	34.08	Upgrade
Total Liabilities	110.46	40.22	5.82	77.62	84.96	93.31	109.97	103.58	64.71	38.02	Upgrade
Total Debt	43.77	14.12	1.59	70.35	79.53	82.05	93.48	91.98	21.97	18.95	Upgrade
Debt Growth	209.88%	789.36%	-97.74%	-11.54%	-3.07%	-12.23%	1.63%	318.76%	15.90%	377.40%	Upgrade
Retained Earnings	-399.78	-353.73	-267.03	-258.47	-245.71	-221.19	-164.73	-121.34	-104.82	-50.16	Upgrade
Comprehensive Income	-0.04	0.11	0	0	0	0	0	0	0	0	Upgrade
Shareholders' Equity	61.86	75.12	127.12	-66.41	-74.46	-66.57	-57.52	-18.7	-10.12	-48.51	Upgrade
Net Cash / Debt	23.97	68.72	110.76	-66.03	-75.97	-59.67	-50.15	-23.12	29.35	-8.7	Upgrade
Net Cash / Debt Growth	-65.12%	-37.95%	-	-	-	-	-	-	-	-	Upgrade
Net Cash Per Share	0.68	1.99	3.72	-16.59	-40.99	-53.25	-54.76	-25.34	63.74	-58.45	Upgrade
Working Capital	13.22	80.81	110.83	0.85	1.54	11.72	34.39	67.72	45.74	6.34	Upgrade
Book Value Per Share	1.75	2.18	4.27	-16.68	-40.17	-59.40	-62.80	-20.49	-21.98	-325.96	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).